期刊文献+

门脉高压症患者围手术期应用复方甘草酸苷的疗效观察 被引量:2

Observation of the Therapeutic Effect of Compound Glycyrrhizin on Portal Hypertension Patients during the Perioperative Period
在线阅读 下载PDF
导出
摘要 目的观察门脉高压症患者手术前、后应用复方甘草酸苷的临床疗效。方法13例门脉高压症并发消化道出血患者,在一般常规治疗基础上,应用复方甘草酸苷注射液60ml~80ml加入5%葡萄糖注射液250ml中静脉滴注,1次/d,术前连用5d~10d,术后继续应用1wk~2wk。结果术前症状、体征及肝功能显著改善;术后肝功能变化不大,腹水发生率下降,腹水程度减轻,与对照组比较有极显著性差异(P<0.01)。结论门脉高压症患者围手术期应用复方甘草酸苷,可显著改善病情,保护肝功能,降低术后腹水的发生率及减轻腹水程度。 OBJECTIVE:To observe the clinical therapeutic effect of compound glycyrrhizin on portal hypertension pa-tients between and after the operative period.METHODS:Apart from a general treatment,13patients with portal hypertension and the complication of the alimentary tract hemorrhage were also administered by drip phleboclysis with60ml to80ml of compound glycyrrhizin injection,which were added to250ml glucose injection at a concentration of5%,once a day for5to10days before the operation and continue for1to2weeks after the operation.RESULTS:The preoperative symptoms,signs and liver function showed a significant improvement;no significant changes were found in the liver function after operation,the incidence of the ascites lowered and the degree of the ascites lowered too,which had a significant difference compared with the control group(P<0.01).CONCLUSION:The portal hypertension patients should be treated with compound glycyrrhizin,in that case,the pathogenetic condition will be improved,the liver function can be protected,the incidence of the ascites will be reduced and the degree of the ascites will be lowered.
作者 李韶山
出处 《中国药房》 CAS CSCD 北大核心 2005年第9期691-692,共2页 China Pharmacy
关键词 复方甘草酸苷 门脉高压症 围手术期 Compound glycyrrhizin Portal hypertension Perioperative period
  • 相关文献

参考文献4

二级参考文献4

  • 1陈国桢.内科学[M].人民卫生出版社,1986.23.
  • 2宋士德.实用医药管理学[M].武汉:武汉测绘科技大学出版社,1994.193.
  • 3日野 邦彦 等.慢性肝炎和复方甘草甜素注射液疗法[J].(日文资料)医学和药学,1994,31(2):2-2.
  • 4Hiromitsu K.Long term treatment of chronic hepatitisC with glycyrrhizinzin[Stronger Neo- Mimophagen C(SNMC) ]for preventing liver cirrhosis and heaptocellular carcinoma[ J ] . Oncology, 2002,69: 94.

共引文献208

同被引文献50

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部